← Open Payments lookup

JENNIFER ROZELLE: Open Payments

NPI 1043634181 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$339 in 15 payments from 7 companies in 2025. Trend: 2023 $370 · 2024 $520 · 2025 $339

Food & beverage: $339
CompanyPaymentsAmount
Lundbeck LLC4$77
Takeda Pharmaceuticals U.S.A., Inc.3$70
Alkermes, Inc.2$53
Otsuka America Pharmaceutical, Inc.2$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Teva Pharmaceuticals USA, Inc.1$25
Boehringer Ingelheim Pharmaceuticals, Inc.1$23

Products named: REXULTI, TRINTELLIX, CAPLYTA, ARISTADA, VIVITROL, UZEDY.

Industry payments across TX — which companies pay providers there.